Financials Geratherm Medical AG
Equities
GME
DE0005495626
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.08 EUR | 0.00% | -0.97% | -24.44% |
2023 | Geratherm Medical AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Geratherm Medical AG Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Valuation
Fiscal Period: December | 2018 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Capitalization 1 | 43.81 | 41.48 | 27.17 | 22.14 | 22.14 | - |
Enterprise Value (EV) 1 | 43.81 | 41.48 | 27.17 | 18.74 | 19.84 | 17.24 |
P/E ratio | 38.5 x | 419 x | 25 x | 15.7 x | -81.6 x | 19.4 x |
Yield | 4.52% | - | - | 5.15% | - | 4.17% |
Capitalization / Revenue | 2.04 x | - | - | 0.88 x | 1.12 x | 0.95 x |
EV / Revenue | 2.04 x | - | - | 0.74 x | 1 x | 0.74 x |
EV / EBITDA | 15.6 x | - | - | 4.07 x | 13.2 x | 3.83 x |
EV / FCF | - | - | - | 7.21 x | 198 x | 6.63 x |
FCF Yield | - | - | - | 13.9% | 0.5% | 15.1% |
Price to Book | 2.16 x | - | - | 0.94 x | 1 x | 0.94 x |
Nbr of stocks (in thousands) | 4,950 | 4,950 | 5,445 | 5,427 | 5,427 | - |
Reference price 2 | 8.850 | 8.380 | 4.990 | 4.080 | 4.080 | 4.080 |
Announcement Date | 4/25/19 | 4/26/22 | 6/29/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net sales 1 | 21.52 | - | - | 25.3 | 19.8 | 23.3 |
EBITDA 1 | 2.801 | - | - | 4.6 | 1.5 | 4.5 |
EBIT 1 | 1.987 | - | - | 3.2 | -0.3 | 2.4 |
Operating Margin | 9.23% | - | - | 12.65% | -1.52% | 10.3% |
Earnings before Tax (EBT) 1 | - | - | - | 3 | -0.5 | 2.1 |
Net income 1 | 1.154 | 0.1222 | 1.023 | 1.4 | -0.3 | 1.2 |
Net margin | 5.36% | - | - | 5.53% | -1.52% | 5.15% |
EPS 2 | 0.2300 | 0.0200 | 0.2000 | 0.2600 | -0.0500 | 0.2100 |
Free Cash Flow 1 | - | - | - | 2.6 | 0.1 | 2.6 |
FCF margin | - | - | - | 10.28% | 0.51% | 11.16% |
FCF Conversion (EBITDA) | - | - | - | 56.52% | 6.67% | 57.78% |
FCF Conversion (Net income) | - | - | - | 185.71% | - | 216.67% |
Dividend per Share 2 | 0.4000 | - | - | 0.2100 | - | 0.1700 |
Announcement Date | 4/25/19 | 4/26/22 | 6/29/23 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | - | - | - | 3.4 | 2.3 | 4.9 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | - | 2.6 | 0.1 | 2.6 |
ROE (net income / shareholders' equity) | - | - | - | 8.5% | -1.7% | 6.1% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - |
Book Value Per Share 2 | 4.110 | - | - | 4.330 | 4.060 | 4.320 |
Cash Flow per Share 2 | - | - | - | 0.7200 | 0.1400 | 0.6100 |
Capex 1 | - | - | - | 2 | 1.6 | 1.6 |
Capex / Sales | - | - | - | 7.91% | 8.08% | 6.87% |
Announcement Date | 4/25/19 | 4/26/22 | 6/29/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.44% | 23.64M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.36% | 26.25B | |
+2.07% | 26.48B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- GME Stock
- Financials Geratherm Medical AG